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ABSTRACT 
The matricellular protein, secreted protein acidic and rich in cysteine (SPARC), 
mediates the interaction between cells and their surrounding extracellular matrix 
(ECM) but does not contribute structurally to the matrix. It regulates basic 
cellular functions such as cell adhesion and proliferation, as well as the 
processing and deposition of ECM proteins. SPARC is overexpressed in many 
fibrotic tissues including the lung. SPARC also serves as a down-stream 
mediator of transforming growth factor-beta (TGF-β), a key driver of airway 
remodeling in chronic airways disease, and demonstrates context-dependent 
immunoregulatory functions. Although airway inflammation and remodeling are 
prominent features of asthma and chronic obstructive pulmonary disease 
(COPD), the role of SPARC in these conditions has not been studied. 
 
In this thesis, we investigated the expression of SPARC in airway structural 
cells including airway epithelial cells (AECs) and airway smooth muscle (ASM) 
cells, and also determined if its expression is altered in cells derived from 
subjects with asthma or COPD. We demonstrated that TGF-β increases 
SPARC expression and release in AECs and ASM cells, although to a lesser 
extent in the former. We observed that type 1 and type 2 cytokines tend to 
suppress basal and TGF-β-mediated SPARC expression in AECs, and showed 
that TGF-β-induced SPARC expression in ASM cells is regulated by the 
unfolded protein response (UPR). Notably, we observed distinct abnormalities 
in SPARC expression in asthma and COPD. Our preliminary studies suggest 
SPARC is overexpressed in AECs from subjects with asthma. In contrast, there 
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was a trend for reduced SPARC expression in ASM cells from COPD subjects, 
compared to those from non-COPD subjects. Functional studies indicate 
SPARC does not impart immunoregulatory functions or regulate changes in 
airway epithelial cell phenotype, although this requires further validation. 
 
Our studies herein also explored the potential homeostatic role of extracellular 
high mobility group box 1 (HMGB1) in AECs. HMGB1 is a danger-associated 
molecular pattern (DAMP) that normally resides in the intracellular 
compartment, and is released into the extracellular space upon cellular injury, 
stress or death to orchestrate inflammatory responses. Although it is implicated 
as a mediator of the airway inflammatory response, its physiological role in lung 
homeostasis has received little attention. Interestingly, we detected HMGB1 in 
the culture supernatant of AECs under basal conditions, and found that it 
presents exclusively as a constituent of protein complexes. Using liquid 
chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomic 
approaches, we generated an unbiased profile of HMGB1-binding proteins in 
the extracellular space of unstimulated AECs. Protein network analysis of 
identified binding proteins indicates a role for extracellular HMGB1 in epithelial 
cell homeostasis and airway mucosal immunity. 
 
In summary, findings in this thesis suggest aberrant regulation of SPARC 
expression in airway structural cells may be a contributing factor to the 
pathogenesis of chronic airways disease. Our studies also provide a new 
understanding of the extracellular functions of HMGB1 in AECs and opens new 
research directions for its use as a therapeutic target. 
